Mokuno et al.[20] determined the serum CA-III levels in 143 patients with 4 types of progressive muscular dystrophy (limb-girdle dystrophy (LG), duchenne muscular dystrophy (DMD), facioscapulohumeral dystrophy (FSH), and congenital dystrophy). This evidence concerns the gene CA3 and Facioscapulohumeral dystrophy.